User profiles for C. K. Yinda

Claude Kwe Yinda

NIAID/NIH
Verified email at nih.gov
Cited by 5259

[HTML][HTML] Ecology, evolution and spillover of coronaviruses from bats

…, T Lunn, A Morris, CE Snedden, CK Yinda… - Nature Reviews …, 2022 - nature.com
In the past two decades, three coronaviruses with ancestral origins in bats have emerged
and caused widespread outbreaks in humans, including severe acute respiratory syndrome …

[HTML][HTML] SARS-CoV-2 infection and persistence in the human body and brain at autopsy

…, SC Ramelli, A Grazioli, JY Chung, M Singh, CK Yinda… - Nature, 2022 - nature.com
Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction 1 , 2 – 3
during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …

[HTML][HTML] Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

…, J Schulz, N Van Doremalen, I Leighton, CK Yinda… - Nature, 2020 - nature.com
Effective therapies to treat coronavirus disease 2019 (COVID-19) are urgently needed. While
many investigational, approved, and repurposed drugs have been suggested as potential …

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

…, T Bushmaker, A Carmody, JR Port, CK Yinda… - Science translational …, 2021 - science.org
ChAdOx1 nCoV-19/AZD1222 is an approved adenovirus-based vaccine for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) currently being deployed globally. Previous …

[HTML][HTML] Effectiveness of N95 respirator decontamination and reuse against SARS-CoV-2 virus

…, MJ Matson, T Bushmaker, CK Yinda… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
The coronavirus pandemic has created worldwide shortages of N95 respirators. We analyzed
4 decontamination methods for effectiveness in deactivating severe acute respiratory …

[HTML][HTML] Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis

…, P De Bruyn, L Beller, W Deboutte, CK Yinda… - Scientific reports, 2015 - nature.com
A major limitation for better understanding the role of the human gut virome in health and
disease is the lack of validated methods that allow high throughput virome analysis. To …

[HTML][HTML] K18-hACE2 mice develop respiratory disease resembling severe COVID-19

CK Yinda, JR Port, T Bushmaker, I Offei Owusu… - PLoS …, 2021 - journals.plos.org
SARS-CoV-2 emerged in late 2019 and resulted in the ongoing COVID-19 pandemic.
Several animal models have been rapidly developed that recapitulate the asymptomatic to …

[HTML][HTML] Effect of environmental conditions on SARS-CoV-2 stability in human nasal mucus and sputum

MJ Matson, CK Yinda, SN Seifert… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
We found that environmental conditions affect the stability of severe acute respiratory
syndrome coronavirus 2 in nasal mucus and sputum. The virus is more stable at low-temperature …

SARS-CoV-2 infection and persistence throughout the human body and brain

…, S Ramelli, A Grazioli, JY Chung, M Singh, CK Yinda… - 2021 - researchsquare.com
COVID-19 is known to cause multi-organ dysfunction 1-3 in acute infection, with prolonged
symptoms experienced by some patients, termed Post-Acute Sequelae of SARS-CoV-2 (…

[HTML][HTML] SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters

JR Port, CK Yinda, IO Owusu, M Holbrook… - Nature …, 2021 - nature.com
Transmission of SARS-CoV-2 is driven by contact, fomite, and airborne transmission. The
relative contribution of different transmission routes remains subject to debate. Here, we show …